Spots Global Cancer Trial Database for Myo-inositol Versus Clomiphene Citrate in PCOS
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Myo-inositol Versus Clomiphene Citrate in PCOS
Official Title: Myo-inositol Versus Clomiphene Citrate as First Line Treatment for Ovulation Induction in PCOS
Study ID: NCT04306692
Study Description
Brief Summary: Specific aim: To compare inositol and the golden standard first line treatment of ovulation induction, namely clomiphene citrate.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
University Hospital, Ghent, , Belgium
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
